Medline Canada Shares Tips on Effective Mask Wearing as Flu Season Approaches

2022-09-16 20:13:24 By : Mr. Gordon Zhang

MISSISSAUGA, ON , Sept. 16, 2022 /CNW/ - If you're riding transit in any Canadian city, the public announcement system will tell you the next stop, it will ask you to stand clear of the closing doors — it might also tell you that wearing a mask is still strongly recommended.

Flu season is around the corner – Medline Canada offers tips to remember when masking up.

While mask mandates throughout the country continue to withdraw, many people still choose to wear them as a personal choice.

With fall — and flu season and a potential new wave of COVID-19 — around the corner, many people might consider wearing PPE to feel more comfortable in various settings. Here are five reminders and tips to remember when masking up:

The basics We've all worn masks over the last two years, but here are some cardinal rules to keep in mind:

Wash your hands or use hand sanitizer before handling your mask

Choose a mask that is clean, dry and has no damage

Make sure your mask fits well over your nose, mouth and chin

Be aware of the mask you choose Several options are now readily available: respirators, medical masks, cloth masks, face shields, bandanas, etc. Health Canada clarifies that while non-medical masks offer protection, the best choices are medical masks and respirators like N95s.

Don't be afraid to change your mask If your mask is dirty or damp, it's time to swap it out with a clean one. Carry a small bag to store your dirty masks.

Reuse masks when possible Many disposable masks use lots of plastic. When thrown in the garbage, this increases the amount of landfill. Locally, there might be a mask recycling program available. Of course, you don't always have to throw your masks in the trash. Cloth masks can be washed by hand or in the washing machine with warm, soapy water and then left to dry.

As for medical masks and respirators, The New York Times noted that experts say storing masks separately with enough time (five to seven days) for the virus to be inactive is safe. A writer in the Times suggests the following: "I have five masks on rotation and seven brown paper bags marked with the days of the week, lined up on my windowsill. I place my mask in the appropriately labelled bag between uses during the day and at the end of it." 1

Fold and store face masks appropriately. Face masks should be carefully folded, so the outer surface is held inward and against itself to reduce contact with the outer surface during storage. The folded mask can be stored between uses in a clean, sealable paper bag or breathable container.

Medline is committed to providing all the tools and tips possible to have all the necessary information on preserving your PPE should you be waiting on your supplies. For more insights and practical advice on conservation strategies, skin health or how to extend the life of your linens, see Medline's readiness resources on the COVID-19 Resource Center.

[1] https://www.nytimes.com/wirecutter/blog/how-to-reuse-n95-kn95-and-other-disposable-masks/

Medline Canada , Corporation Medline is a leading global manufacturer and provider of high-quality medical products and services to the healthcare industry. Our expertise in healthcare solutions throughout the continuum of care, coupled with the scale and agility of our supply chain, allows us to partner with our customers to enhance patient care, improve clinical outcomes, drive effective cost management and provide fast access to quality products.

By applying our CARES values every day, in all that we do, Medline Canada is deeply committed to the health and wellbeing of our customers, employees, partners and communities. With more than 550 employees, including 125 dedicated sales and clinical professionals, and eight distribution centres across Canada , we are a trusted partner in delivering the healthcare needs of Canadians from coast-to-coast – Together Improving Care™. For more information, visit: www.medline.ca

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2022/16/c9423.html

Investors have lost patience with the slow-paced clinical trials of genetic therapies, and some are using the upbeat news to exit Intellia and peers.

Stéphane Bancel discusses the company’s latest Covid shot and prospects for using mRNA in seasonal flu vaccines and personalized treatments for cancer

Intellia said Friday it knocked out the gene responsible for a rare and deadly swelling disorder. But CRISPR stocks sank.

Gilead Sciences Inc (NASDAQ: GILD) announced updates to the World Health Organization's (WHO) Therapeutics and COVID-19: living guideline, which now conditionally recommends Veklury (remdesivir) for severe COVID-19. WHO continues to conditionally recommend Veklury in those with non-severe COVID-19 at the highest risk of hospitalization. The WHO conditional recommendation is mainly driven by the final results of the WHO-sponsored SOLIDARITY study, which showed a statistically significant 17% lowe

J&J (JNJ) announces a new $5 billion stock buyback plan. CHMP recommends authorizing Pfizer's (PFE) Omicron BA.4 and BA.5 boosters in Europe.

In a recent interview with PEOPLE, the couple, whose real-life love story was portrayed in The Big Sick, opened up about what it's like to be in the immunocompromised community

The latest clinical news from Bristol Myers Squibb (NYSE: BMY) was quite encouraging, sufficient to drive the pharmaceutical giant's stock higher on an otherwise uninspired day for the broader stock market. Bristol Myers Squibb's share price experienced a nearly 2% bump, a notably better showing than the S&P 500 index's more than 1% decline. Bristol Myers Squibb's good news from the lab was that its enduringly popular cancer drug Opdivo did quite well in its latest round of testing.

Regeneron (REGN) and its partner Alnylam announce promising data from its ongoing phase I study evaluating ALN-HSD in healthy adults and NASH patients.

Eloxx Pharmaceuticals' (ELOX) phase II combination study evaluating pipeline candidate ELX-02 in cystic fibrosis fails to achieve statistical significance in efficacy endpoints.

Intellia Therapeutics said two of its experimental Crispr treatments produced positive results in early-stage trials.

"If we are forcing millions of people into this world, we as a society — whether you are right, whether you are left, whether you are 'pro-life' or not — it doesn't matter. You will all suffer the consequences of a crowded, broken political, healthcare, and education system."View Entire Post ›

Biotech stocks have swung sharply higher, buoyed by several factors. Could they be poised to lead the market though the next big upturn?

The following two healthcare stocks look like great buys for investors seeking to collect both above-average income and increase wealth. The good news for cancer patients is that Merck's (NYSE: MRK) cancer drug called Keytruda is approved in the U.S. to treat 19 different forms of the disease. Looking out over the long term, Merck's pipeline is just as strong as its existing products.

Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?

How do you fix a forgetful memory? Neurologist shares brain exercises to keep memory sharp, including reading fiction, cooking from recipes and playing games.

Adverum (ADVM) initiates dosing in the phase II LUNA study, currently investigating its lead product candidate ixoberogene soroparvovec for wet age-related macular degeneration.

The San Carlos company has 125 employees and is applying its pulsed electric field systems in lung cancer and, potentially, drug delivery.

Shares of Intellia Therapeutics Inc. gained 6.5% in premarket trading on Friday after the company and Regeneron Pharmaceuticals Inc. announced positive data from an ongoing Phase 1 clinical trial evaluating their investigational Crispr therapy as a treatment for transthyretin amyloidosis with cardiomyopathy, which can cause heart failure. The data demonstrated a reduction in serum transthyretin in 12 patients for up to six months. "At these deep and consistent levels of protein reduction, we bel

In June, a Dallas area doctor who was feeling unwell wanted to use a saline IV bag she had gotten from her work to try to rehydrate. She tapped it into her veins while at home. Minutes later, she suffered a major medical event and died, court records say. Now, Raynaldo Rivera Ortiz Jr., an anesthesiologist at her surgical facility, faces federal charges for allegedly tampering with IV bags in a way that resulted in the death of his colleague as well as several other cardiac emergencies, accordin

Regulatory and pipeline updates from BMY and REGN are the key highlights from the biotech sector during the past week.